UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 219

Sortiert nach

Cumulative childhood risk is associated with a new measure of chronic inflammation in adulthood

Journal of child psychology and psychiatry, 2019-02, Vol.60 (2), p.199-208

2019

Link zum Volltext

Verfügbarkeit prüfen

suPAR: A New Biomarker for Cardiovascular Disease?

Canadian journal of cardiology, 2015-10, Vol.31 (10), p.1293-1302

2015

Link zum Volltext

Verfügbarkeit prüfen

Overall and inter-individual effect of four different drug classes on soluble urokinase plasminogen activator receptor in type 1 and type 2 diabetes

Diabetes, obesity & metabolism, 2023-11, Vol.25 (11), p.3152-3160

2023

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of commercially available immuno‐magnetic agglutination in comparison to enzyme‐linked immunosorbent assays for rapid point‐of‐care diagnostics of COVID‐19

Journal of medical virology, 2021-05, Vol.93 (5), p.3084-3091

2021

Link zum Volltext

Verfügbarkeit prüfen

Chronic inflammation markers and cytokine-specific autoantibodies in Danish blood donors with restless legs syndrome

Scientific reports, 2022-01, Vol.12 (1), p.1672-1672, Article 1672

2022

Link zum Volltext

Verfügbarkeit prüfen

Robust Hepatitis C Genotype 3a Cell Culture Releasing Adapted Intergenotypic 3a/2a (S52/JFH1) Viruses

Gastroenterology (New York, N.Y. 1943), 2007-11, Vol.133 (5), p.1614-1626

2007

Link zum Volltext

Verfügbarkeit prüfen

SuPAR, biomarkers of inflammation, and severe outcomes in patients hospitalized for COVID‐19: The International Study of Inflammation in COVID‐19

Journal of medical virology, 2024-01, Vol.96 (1), p.e29389-n/a

2024

Link zum Volltext

Verfügbarkeit prüfen

suPAR cut-offs for stratification of low, medium, and high-risk acute medical patients in the emergency department

BMC emergency medicine, 2021-11, Vol.21 (1), p.1-149, Article 149

2021

Link zum Volltext

Verfügbarkeit prüfen

Circulating suPAR associates with severity and in‐hospital progression of COVID‐19

European journal of clinical investigation, 2022-07, Vol.52 (7), p.e13794-n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia

Critical care (London, England), 2020-04, Vol.24 (1), p.187-187, Article 187

2020

Link zum Volltext

Verfügbarkeit prüfen

Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19

Journal of the American Heart Association, 2021-12, Vol.10 (24), p.e023535-e023535

2021

Link zum Volltext

Verfügbarkeit prüfen

Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation

Frontiers in immunology, 2021-12, Vol.12, p.780641-780641

2021

Link zum Volltext

Verfügbarkeit prüfen

Highly Efficient JFH1-Based Cell-Culture System for Hepatitis C Virus Genotype 5a: Failure of Homologous Neutralizing-Antibody Treatment to Control Infection

The Journal of infectious diseases, 2008-12, Vol.198 (12), p.1756-1765

2008

Link zum Volltext

Verfügbarkeit prüfen

suPAR: the molecular crystal ball

Disease markers, 2009-01, Vol.27 (3), p.157-172

2009

Link zum Volltext

Verfügbarkeit prüfen

suPAR Cut-Offs for Risk Stratification in Patients With Symptoms of COVID-19

Biomarker insights, 2021, Vol.16, p.11772719211034685

2021

Link zum Volltext

Verfügbarkeit prüfen

Plasma suPAR is lowered by smoking cessation: a randomized controlled study

European journal of clinical investigation, 2016-04, Vol.46 (4), p.305-311

2016

Link zum Volltext

Verfügbarkeit prüfen

An open label trial of anakinra to prevent respiratory failure in COVID-19

eLife, 2021-03, Vol.10

2021

Link zum Volltext

Verfügbarkeit prüfen

Effects of liraglutide on cardiovascular risk biomarkers in patients with type 2 diabetes and albuminuria: A sub‐analysis of a randomized, placebo‐controlled, double‐blind, crossover trial

Diabetes, obesity & metabolism, 2017-06, Vol.19 (6), p.901-905

2017

Link zum Volltext

Verfügbarkeit prüfen

Development and validation of prognostic machine learning models for short- and long-term mortality among acutely admitted patients based on blood tests

Scientific reports, 2024-03, Vol.14 (1), p.5942-5942

2024

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory biomarkers and cancer: CRP and suPAR as markers of incident cancer in patients with serious nonspecific symptoms and signs of cancer

International journal of cancer, 2017-07, Vol.141 (1), p.191-199

2017

Link zum Volltext

Verfügbarkeit prüfen

Self-rated health and chronic inflammation are related and independently associated with hospitalization and long-term mortality in the general population

Scientific reports, 2022-11, Vol.12 (1), p.19761-19761, Article 19761

2022

Link zum Volltext

Verfügbarkeit prüfen

Using soluble urokinase plasminogen activator receptor to stratify patients for medication review in the emergency department

British journal of clinical pharmacology, 2022-02, Vol.88 (4), p.1679-1690

2022

Link zum Volltext

Verfügbarkeit prüfen

Effects of 1 year of exercise training versus combined exercise training and weight loss on body composition, low-grade inflammation and lipids in overweight patients with coronary artery disease: a randomized trial

Cardiovascular diabetology, 2019-10, Vol.18 (1), p.127-127, Article 127

2019

Link zum Volltext

Verfügbarkeit prüfen

Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study

Emergency medicine journal : EMJ, 2016-11, Vol.33 (11), p.769-775

2016

Link zum Volltext

Verfügbarkeit prüfen

Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis

The Journal of clinical investigation, 2022-12, Vol.132 (24), p.1-14

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 219

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(202)
Mit Volltextzugriff
(201)

Publikationsform

Artikel
(219)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(169)
Life Sciences & Biomedicine
(152)
Humans
(136)
Male
(100)
Female
(93)
Middle Aged
(85)
Adult
(68)
Aged
(54)
Mortality
(50)
Biomarkers
(48)
Receptors, Urokinase Plasminogen Activator - Blood
(46)
Biomarkers - Blood
(43)
Infectious Diseases
(42)
Inflammation
(42)
Cohort Studies
(36)
Prognosis
(36)
Biological And Medical Sciences
(34)
Immunology
(32)
Risk Factors
(32)
Supar
(32)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Cumulative childhood risk is associated with a new measure of chronic inflammation in adulthood

suPAR: A New Biomarker for Cardiovascular Disease?

Overall and inter-individual effect of four different drug classes on soluble urokinase plasminogen activator receptor in type 1 and type 2 diabetes

Evaluation of commercially available immuno‐magnetic agglutination in comparison to enzyme‐linked immunosorbent assays for rapid point‐of‐care diagnostics of COVID‐19

Chronic inflammation markers and cytokine-specific autoantibodies in Danish blood donors with restless legs syndrome

Robust Hepatitis C Genotype 3a Cell Culture Releasing Adapted Intergenotypic 3a/2a (S52/JFH1) Viruses

SuPAR, biomarkers of inflammation, and severe outcomes in patients hospitalized for COVID‐19: The International Study of Inflammation in COVID‐19

suPAR cut-offs for stratification of low, medium, and high-risk acute medical patients in the emergency department

Circulating suPAR associates with severity and in‐hospital progression of COVID‐19

Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia

Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19

Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation

Highly Efficient JFH1-Based Cell-Culture System for Hepatitis C Virus Genotype 5a: Failure of Homologous Neutralizing-Antibody Treatment to Control Infection

suPAR: the molecular crystal ball

suPAR Cut-Offs for Risk Stratification in Patients With Symptoms of COVID-19

Plasma suPAR is lowered by smoking cessation: a randomized controlled study

An open label trial of anakinra to prevent respiratory failure in COVID-19

Effects of liraglutide on cardiovascular risk biomarkers in patients with type 2 diabetes and albuminuria: A sub‐analysis of a randomized, placebo‐controlled, double‐blind, crossover trial

Development and validation of prognostic machine learning models for short- and long-term mortality among acutely admitted patients based on blood tests

Inflammatory biomarkers and cancer: CRP and suPAR as markers of incident cancer in patients with serious nonspecific symptoms and signs of cancer

Self-rated health and chronic inflammation are related and independently associated with hospitalization and long-term mortality in the general population

Using soluble urokinase plasminogen activator receptor to stratify patients for medication review in the emergency department

Effects of 1 year of exercise training versus combined exercise training and weight loss on body composition, low-grade inflammation and lipids in overweight patients with coronary artery disease: a randomized trial

Soluble urokinase plasminogen activator receptor (suPAR) in acute care: a strong marker of disease presence and severity, readmission and mortality. A retrospective cohort study

Increased soluble urokinase plasminogen activator levels modulate monocyte function to promote atherosclerosis

Suchergebnisse filtern